Inhibition of radiation-induced lymphatic leukemia in C57BL mice by 19S alpha-2-globulin (alpha 2-MG) from human blood serum.
Berenblum
I
I
Burger
M
M
Knyszynski
A
A
D000818:Animals; D004260:DNA Repair / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007942:Leukemia, Experimental / Q000209:etiology / Q000517:prevention & control*; D007953:Leukemia, Radiation-Induced / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D012756:Sheep; D013045:Species Specificity; D013154:Spleen / Q000737:chemistry; D014916:Whole-Body Irradiation / Q000009:adverse effects*; D000511:alpha-Macroglobulins / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*
D011837:Radiation-Protective Agents; D000511:alpha-Macroglobulins